Clinical trial
Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure (ASCEND-HF)
NCT00475852 is registered in ClinicalTrials.gov with Scios, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure (ASCEND-HF)
- Lead sponsor
- Scios, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2007
- Completion date
- March 31, 2011
- Enrollment
- 7,141 (actual)
- Sites
- 328
Conditions
As the registry lists them; a condition with its own page is linked.
heart decompensation